Ignatiev V G, Vishlenkova E A, Zatravkin S N
N. A. Semashko National Research Institute of Public Health, 105064, Moscow, Russia.
The Ludwig-Maximilian University of Munich, 80539, Munich, Germany.
Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med. 2024 Jul;32(4):863-869. doi: 10.32687/0869-866X-2024-32-4-863-869.
In the history of the Russian pharmaceutical market the year of 1993 became the year of formation of rules of market relations and changing under them of market landscape. The significant segment of state-centralized purchases moved under responsibility of regional authorities and their health care authorities. At that, powers of three former state organizations being occupied with purchases of imported medications were distributed between new state companies of Ministry of Health and commercial organizations and firms that entered pharmaceutical market. This diversity rather soon gave rise to competitive fight for budget funds and experiments of Government with market regulation. The traces of these clashes and attempts to make market regulated can be found in Ministry of Health archives and journal publications. The Report I reveals circumstances of entrance of Ministry of Health into market relationships and its acquisition of market player identity.
在俄罗斯药品市场的历史上，1993年成为了市场关系规则形成以及市场格局随之改变的一年。国家集中采购的重要部分转由地区当局及其医疗保健部门负责。当时，三个曾负责进口药品采购的原国家组织的权力，在卫生部的新国有公司以及进入药品市场的商业组织和公司之间进行了分配。这种多样性很快引发了对预算资金的竞争以及政府对市场监管的尝试。这些冲突以及使市场得到规范的尝试的痕迹，可以在卫生部的档案和期刊出版物中找到。报告一揭示了卫生部进入市场关系以及获得市场参与者身份的情况。
